Select Page

Press

  • Summiting on Immunogenicity and Epitope Networks

    Summiting on Immunogenicity and Epitope Networks

    Posted on October 11, 2012 by Annie De Groot
    EpiVax is attending the Immunogenicity Summit in Bethesda this week. Look for Leslie and Annie in person (Annie is usually at the microphone asking questions about HLA associations). We will be piloting some new slides on Epitope Networks. (For more on that, see the link to our CHO/Host Cell protein talk, which is also available ...
    Read more
  • Tregitope World Tour Fall 2012

    Tregitope World Tour Fall 2012

    Posted on October 2, 2012 by Anthony Marcello
    Our Tregitope tour continues this month and on through the fall including stops in Orlando, Bethesda and Yokohama. Take a look at the list below and let us know if you’d like us to visit you while we’re in the area. ICIW 2012 Tutorial Session 10/7 – 10/10 In conjunction with: ACM International Conference on Bioinformatics and Computational ...
    Read more
  • EpiVax Awarded SBIR Phase II for Further Proof of Principle Studies

    Posted on September 5, 2012 by Anthony Marcello
    EpiVax Grant for treatment of Pompe Disease brings SBIR infusion to $3.4M for Proof of Principle Studies  Providence, RI – Providence-based biotech EpiVax, Inc. was awarded a new NIH SBIR Phase II grant totaling $300,000 in funding from the National Institutes of Health (NIH) NIAID for the first year of a two year program to application of Tregitope to Pompe ...
    Read more
  • There must be something "there" there: Tregitopes and FVIII

    Posted on July 26, 2012 by Annie De Groot
    EpiVax, Inc, a leader in genome-derived vaccines, announced today that it has received a $750,000 SBIR Phase Igrant to reengineer factor eight (FVIII), the primary therapeutic used to control bleeding and foster wound healing in hemophiliacs.
    Read more
  • EpiVax to attend ICIW 2012

    EpiVax to attend ICIW 2012

    Posted on July 26, 2012 by Anthony Marcello
    The Third Immunoinformatics and Computational Immunology Workshop will be held in conjunction with the ACM International Conference on Bioinformatics and Computational Biology in Orlando, FL on October 7-10 2012. The main theme of this meeting is “Bridging Immunology and Computer Science“. Nowadays computational methods are integral to virtually every research and development project in every discipline. ...
    Read more
  • The "I" in Bio [technology]: Tell us your story

    Posted on June 9, 2012 by Annie De Groot
    What’s the “I” in Biotechnology? We’re having a contest – on line and in person (at Bio). We challenge you to write 250 words on why you engage in Biotechnology. What’s your passion? What’s the story? What’s the impact? Let the world know. The best essays will be published on right here at our “Thinking out ...
    Read more
  • Happy Birthday Up Start Biotech! EpiVax Turns 14!

    Happy Birthday Up Start Biotech! EpiVax Turns 14!

    Posted on May 18, 2012 by Annie De Groot
    14 years ago today, I was making pancakes for Bill in my kitchen, because EpiVax offices were on the third floor of my house. We were a virtual startup – no lab, but great coffee, home-made pancakes, and lots of innovative ideas about how to make new vaccines and biotherapeutics. At the end of the ...
    Read more
  • Tregitope Goes to Granada (Autoimmunity 2012)

    Tregitope Goes to Granada (Autoimmunity 2012)

    Posted on May 12, 2012 by Annie De Groot
    Even though there are as many kinds of Tregs as there are types of tapas in Granada, there is only one Tregitope. The copas are flowing, and the Tregitope discovery (OK, make that SEVERAL Tregitopes) is being presented to the >3,000 participants at Autoimmunity 2012. The excitement is palpable . . .
    Read more
  • "Live Fire" Test: Defense Funding for EpiVax Technology

    Posted on April 20, 2012 by Anthony Marcello
    Vaccines on demand? Yes we can. Our team is connected via international teleconferencing to four other academic and biotech company laboratories across the globe, including scientists in Germany and Denmark, a biochemist in Seattle and a vaccine developer at Harvard . . . EpiVax will play a key role in a new “faster, safer” vaccines ...
    Read more
  • Tregitope Wins Big SBIR Program

    Tregitope Wins Big SBIR Program

    Posted on April 9, 2012 by Annie De Groot
    Providence-based biotech EpiVax, Inc. was awarded a new NIH SBIR Phase II grant totaling $1.5M in funding from the National Institutes of Health’s (NIH) NIDDK to explore formulation, dose, route and delivery vehicle for Tregitope through the NIH Small Business Innovation Research (SBIR) program. EpiVax anticipates receiving an additional SBIR award of approximately $775,000 within ...
    Read more
  • Srini Kaveri to discuss IVIG and Tregitope MOA at 4th Tregitope Update

    Srini Kaveri to discuss IVIG and Tregitope MOA at 4th Tregitope Update

    Posted on April 2, 2012 by Annie De Groot
    The 4th Annual Tregitope update will be held in Baltimore Maryland on April 20th, 2012 (Click here for more information). Dr. Srini Kaveri of the Centre de Recherche des Cordeliers (INSERM) in Paris will provide an update on the mechanism of action of IVIG with an eye to parallels with Tregitope. A wide range ...
    Read more
  • Westin Immunogenicity Seminar March 16th

    Westin Immunogenicity Seminar March 16th

    Posted on March 4, 2012 by Annie De Groot
    The Westin Seminar is back! Join us in Tokyo on March 16th to discuss immunogenicity risk and mitigation.
    Read more
  • Spring 2012 Immunogenicity Workshop Schedule

    Spring 2012 Immunogenicity Workshop Schedule

    Posted on February 3, 2012 by Anthony Marcello
    Come participate in one of the following hands-on demonstrations of our bioinformatics tools!  Each of these workshops features presentations and demonstrations led by our expert immunoinformaticians. Learn from the best! Hands-on Workshops! 5th Antibody Generation, Engineering & Design Conference Frankfurt, Germany Le Meridien Parkhotel, Frankfurt, Germany 29th of February 2012 Half-Day Workshop February 29th: Latest Advances in Reducing the Risk of ...
    Read more
  • Happy New Year! Tregitope World Tour 2012

    Happy New Year! Tregitope World Tour 2012

    Posted on January 1, 2012 by Annie De Groot
    It’s a New Year (2012) and our resolution is to keep you better informed. Here’s a list of our upcoming conferences. . . .
    Read more
  • Essential ingredient to Ending AIDS: Political Will

    Posted on December 7, 2011 by Annie De Groot
    “We have something right now that can cure HIV around the world,” said Dr. Annie De Groot, founder and scientific director of Global Alliance to Immunize Against AIDS, based in Providence, and director of the University of Rhode Island’s Institute for Immunology and Informatics. “It’s treatment.”
    Read more

Join our newsletter

We strive to provide our clients, collaborators and everyday immunology enthusiasts with valuable content.  Written by our CEO/CSO Dr. Anne Dr Groot, you can expect up to date vaccine development efforts, upcoming events and so much more from our offices here in Providence, RI.

Click Here